Get involved in ISPOR Science and Health Policy Initiatives Activities – February 2022

Published Feb 21, 2022

Upcoming Journal Clubs

The Health Preference Special Interest Group Journal Club will be hosting two upcoming journal clubs. Journal clubs are focused discussions on specific, published, scientific research papers. It is advised for attendees to read the article prior to participating in the live journal club. Bring your questions for the authors to answer.

  1. The preferred qualities of human immunodeficiency virus testing and self-testing among men who have sex with men: a discrete choice experiment

    Thursday, February 26 | 3:00 PM AEDT |  Journal Club Info

  2. Taking into account patient preferences: A consensus study on the assessment of psychological dimensions within patient preference studies

Wednesday, March 23 | 10:00 AM US ET | Journal Club Info

Short Course on Patient Engagement in Medical-Product Research

Join members of the ISPOR Patient Centered Special Interest Group on 22-23 June 2022 at 10:00AM – 12:00PM EST for a 4-hour short course (course runs 2 consecutive days, 2 hours each day) on “Introduction to Patient Engagement in Medical-Product Research.” This course is designed to provide participants with an introduction to patient engagement (PE) in medical-product research through defining PE and providing its historical context and significance throughout ISPOR’s HEOR taxonomy. This course will also equip attendees with tools to plan and implement meaningful PE activities in their respective areas of research expertise (e.g., clinical development, epidemiology, health economics, real-world evidence, etc.) One of the course’s strengths is that attendees will have the opportunity to interact with stakeholders who represent a variety of perspectives. Interaction with stakeholders and other attendees may also result in unique opportunities for further collaboration in PE medical-product research. For more information and registration, please visit here.

Update from ISPOR Task Forces and Good Practices Reports

Update from ISPOR Special Interest Groups

  • Updates from the ISPOR Patient Centered Special Interest Group
    • New Leadership of the SIG Announced

      ISPOR is pleased to announce new leaders of the Eleanor Perfetto, PhD, MS, Professor of Pharmaceutical Health Service Research, University of Maryland School of Pharmacy, Baltimore, MD, USA, and Jessica Roydhouse, PhD, Select Foundation Senior Research Fellow in Health Services Research, Menzies Institute for Medical Research, University of Tasmania, Australia as the incoming Chair and Chair-Elect of the Special Interest Group, respectively. The SIG will be sending out a survey to gain member feedback on topics and activities related to patient engagement. For the first time, “patient engagement” is included in ISPOR’s Top 10 HEOR Trends. To sign up to be in the SIG and for more information on the ISPOR Patient Centered Special Interest Group, please see here.

    • ISPOR Short Course Focused on an “Introduction to Patient Engagement in Medical-Product Research”Join members of the ISPOR Patient Centered Special Interest Group on 22-23 June 2022 at 10:00AM – 12:00PM EST for a 4-hour short course (course runs 2 consecutive days, 2 hours each day) on “Introduction to Patient Engagement in Medical-Product Research.” This course is designed to provide participants with an introduction to patient engagement (PE) in medical-product research through defining PE and providing its historical context and significance throughout ISPOR’s HEOR taxonomy. This course will also equip attendees with tools to plan and implement meaningful PE activities in their respective areas of research expertise (e.g., clinical development, epidemiology, health economics, real-world evidence, etc.) One of the course’s strengths is that attendees will have the opportunity to interact with stakeholders who represent a variety of perspectives. Interaction with stakeholders and other attendees may also result in unique opportunities for further collaboration in PE medical-product research. For more information and registration, please visit here.

Dialogue with Decision Makers

  • ISPOR Responds to US FDA Call for Comments

    The US Food and Drug Administration recently posted a draft guidance entitled “Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products.” This guidance is intended to provide sponsors, researchers, and other interested stakeholders with considerations when proposing to use electronic health records (EHRs) or medical claims data in clinical studies to support a regulatory decision on effectiveness or safety. ISPOR, with the help of members representing various councils and special interest groups, provided comments.

  • Virtual ISPOR Health Technology Assessment Roundtable – Europe 2021

    On 23 November 2021, 24 attendees from 20 different European countries convened for the Virtual ISPOR HTA Roundtable-Europe. This year the Roundtable focused on two relevant topics: 1) The Role of HTA in Assessing Digital Technologies and Virtual Care and 2) HTA of Potentially Curative Therapies (ATMP). Presentations from HTA Bodies and Academicians (National Health Fund HQ, INFARMED, IQWiG, Gdańsk Medical University, AIFA) among others, discussed the needs to adapt and organize HTA activities around emerging trends. Learn more about HTA Roundtables here.

  • ISPOR Convenes Virtual 2021 Patient Representatives Roundtable – Europe
    The ISPOR 2021 Patient Representatives Roundtable–Europe convened virtually on 9 December 2021 to discuss patient-generated data and evidence in health technology assessment. More than 30 representatives from various patient organizations, research and academia, health technology assessment bodies, life sciences industry, and regulatory agencies participated in the discussion. Some of the participating organizations included EUPATI, IPPOSI, IAPO, European Commission and EMA. Learn more about Patient Representatives Roundtables here.

HEOR Resources

  • Assessing the Evidence for Health Care Decision Makers

ISPOR is updating the Assessing the Evidence for Health Care Decision Makers tool. If you currently utilize this tool, we kindly ask that you log into https://www.healthstudyassessment.org/ and save any study review assessment data you would like to keep in your own file by February 28, 2022. After this date, you will not be able to access your data. More information to come on the New Assessing the Evidence for Health Care Decision Makers. 

  • HTA Central

This year, “health technology assessment” has made the Top 10 HEOR Trends list for the first time, and it is also a key theme in the ISPOR Science Strategy! ISPOR’s Health Technology Assessment (HTA) Central provides a comprehensive repository of resources and tools to support HTA and informed healthcare decisions!

HTA Central is freely available to all and offers information on HTA-related news pertaining to Asia Pacific, Europe, Latin America, Middle East & Africa, and North America, and answers all of your HTA questions on how to promote an equitable, efficient, and high-quality health system, the steps for conducting a thorough health technology assessment, and much more! Visit the ISPOR HTA Central to see our new look and to learn more about HTA. Click here to explore.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×